SCHEMBL4745817

SCHEMBL4745817

c1ccc(-c2cccc(-c3ccccc3)c2-c2cc3c4cccc5c4c(cc3c3ccccc23)-c2ncccc2-5)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TOP2A P11388 1/20 0.36
ALDH1A1 P00352 2/20 0.36
HSD17B10 Q99714 2/20 0.36
HTT P42858 1/20 0.36
PTGS1 P23219 1/20 0.36
PTGS2 P35354 1/20 0.36
PTPRC P08575 2/20 0.35
CTSL P07711 1/20 0.35
CTSS P25774 1/20 0.35
PTPN13 Q12923 1/20 0.35
HPGD P15428 1/20 0.35
TSHR P16473 1/20 0.35
MAPK1 P28482 1/20 0.35
CASP1 P29466 1/20 0.35
HIF1A Q16665 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
MEN1 O00255 1/20 0.34
THRB P10828 1/20 0.34
BLM P54132 1/20 0.34
KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4745821 0.90 PTGS1 (0.40) TOP2AALDH1A1HSD17B10HTTPTGS1
SCHEMBL4746287 0.88 PTPRC (0.39) TOP2AALDH1A1HSD17B10HTTPTGS1
SCHEMBL4746465 0.88 ALDH1A1 (0.39) TOP2AALDH1A1HSD17B10PTPRCCTSL
SCHEMBL4746298 0.87 PTPRC (0.38) TOP2AALDH1A1HSD17B10HTTPTGS1
SCHEMBL4746300 0.87 PTPRC (0.38) TOP2AALDH1A1HSD17B10HTTPTGS1
SCHEMBL4746267 0.87 ALDH1A1 (0.42) TOP2AALDH1A1HSD17B10PTPRCCTSL
SCHEMBL4745799 0.86 TOP2A (0.36) TOP2AALDH1A1HSD17B10HTTPTGS1
SCHEMBL4746335 0.85 ALDH1A1 (0.39) TOP2AALDH1A1HSD17B10HTTPTPRC
SCHEMBL4746392 0.85 ALDH1A1 (0.41) TOP2AALDH1A1HSD17B10PTPRCCTSL
SCHEMBL4746306 0.85 PTGS1 (0.35) TOP2AALDH1A1HSD17B10HTTPTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8173275-B2 Azaindenochrysene derivative and organic light-emitting device CANON KABUSHIKI KAISHA (JP) 2012-05-08 US disclosed
US-8173275-B2 Azaindenochrysene derivative and organic light-emitting device CANON KABUSHIKI KAISHA (JP) 2012-05-08 US disclosed
US-20100117526-A1 NOVEL AZAINDENOCHRYSENE DERIVATIVE AND ORGANIC LIGHT-EMITTING DEVICE CANON KABUSHIKI KAISHA (JP) 2010-05-13 US disclosed
US-20100117526-A1 NOVEL AZAINDENOCHRYSENE DERIVATIVE AND ORGANIC LIGHT-EMITTING DEVICE CANON KABUSHIKI KAISHA (JP) 2010-05-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100117526-A1 NOVEL AZAINDENOCHRYSENE DERIVATIVE AND ORGANIC LIGHT-EMITTING DEVICE NR2E3, OR51E2, AZI2 TOP2A 1041/4885ALDH1A1 179/4885HSD17B10 2132/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.